Dynavax Technologies (DVAX US)

Analysis

Health Care • United States

Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.

Refresh

Company Presentation • 12 Jan 2024 03:15

J.P. Morgan 42nd Annual Healthcare Conference 2024

Company Presentation • 05 Jun 2024 02:20

The 44th Annual William Blair Growth Stock Conference

Company Presentation • 04 Jun 2025 03:40

45th Annual William Blair Growth Stock Conference

Company Presentation • 06 Nov 2025 05:30

Q3 2025

Company Presentation • 08 Aug 2025 04:30

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

J.P. Morgan 42nd Annual Healthcare Conference 2024

The 44th Annual William Blair Growth Stock Conference

45th Annual William Blair Growth Stock Conference

Q3 2025

Q2 2025